Pilot Intervention With Near Infrared Stimulation

NCT03551392 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-01-27

No results posted yet for this study

Summary

The current study will test whether age-related cognitive and mood changes in older adults and those will be affected by near infrared (NIR) stimulation. The overall hypothesis, drawn from previous literature, is that exposure to NIR stimulation will have positive effects on brain health and will result in better cognitive and mood performance.

Conditions

  • Aging

Interventions

DEVICE

Medx Console System

This intervention delivers near infrared (NIR) light using light emitting diodes applied to the head and via an intranasal applicator for a period of approximately 1.5 hours. A total of 16 sessions take place in the lab over 12 weeks.

DEVICE

Sham Medx Console System

This intervention uses sham application of near infrared light (NIR) using light emitting diodes applied to the head and via an intranasal applicator for a period of approximately 1.5 hours. A total of 16 sessions take place in the lab over 12 weeks.

DEVICE

Vielight 810 intranasal stand alone unit

Daily at home intranasal NIR stimulation sessions, 25 minutes in duration, 4 days each week.

DEVICE

Sham Vielight 810 intranasal stand alone unit

Daily at home intranasal "sham" NIR stimulation sessions, 25 minutes in duration, 4 days each week.

Sponsors & Collaborators

  • McKnight Brain Research Foundation

    collaborator UNKNOWN
  • University of Arizona

    collaborator OTHER
  • University of Florida

    lead OTHER

Principal Investigators

  • Dawn Bowers, Ph.D. · University of Florida

  • Adam Woods, Ph.D. · University of Florida

  • Gene Alexander, Ph.D. · University of Arizona

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-26
Primary Completion
2026-04-30
Completion
2026-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03551392 on ClinicalTrials.gov